New Data On Invega(R) Sustenna(R) And Risperdal(R) Consta(R) For Schizophrenia To Be Presented At Major Psychiatry Meeting
New data on INVEGA® SUSTENNA® (paliperidone palmitate), a long-acting injectable medicine for schizophrenia, and new data on RISPERDAL® CONSTA® (risperidone long-acting therapy), also an injectable medicine to treat schizophrenia, will be presented next week at a major psychiatry meeting in New Orleans…
More: continued here
Filed under: Mental Health on May 25th, 2010
You must be logged in to post a comment.